Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. BHR Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M ... N Engl J Med 370 (4), 322-33, 2014 | 2083* | 2014 |
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 758 | 2019 |
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature Medicine 26 (3), 398-407, 2020 | 439 | 2020 |
Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III JM Noble, LN Borrell, PN Papapanou, MSV Elkind, N Scarmeas, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (11), 1206-1211, 2009 | 358 | 2009 |
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease E McDade, G Wang, BA Gordon, J Hassenstab, TLS Benzinger, V Buckles, ... Neurology 91 (14), e1295-e1306, 2018 | 259 | 2018 |
Serum IgG Antibody Levels to Periodontal Microbiota Are Associated with Incident Alzheimer Disease. J Noble, N Scarmeas, RS Celenti, MSV Elkind, CB Wright, N Schupf, ... PLOS One 9 (12), e114959, 2014 | 216 | 2014 |
Association of C-reactive protein with cognitive impairment JM Noble, JJ Manly, N Schupf, MX Tang, R Mayeux, JA Luchsinger Archives of neurology 67 (1), 87-92, 2010 | 205 | 2010 |
Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature JM Noble, N Scarmeas, PN Papapanou Current neurology and neuroscience reports 13 (10), 1-8, 2013 | 191 | 2013 |
Diet and Alzheimer’s disease JA Luchsinger, JM Noble, N Scarmeas Current Neurology and Neuroscience Reports 7 (5), 366-372, 2007 | 189 | 2007 |
Type 2 diabetes and late-onset Alzheimer’s disease D Cheng, J Noble, MX Tang, N Schupf, R Mayeux, JA Luchsinger Dementia and geriatric cognitive disorders 31 (6), 424-430, 2011 | 176 | 2011 |
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ... Neurology 85 (8), 692-700, 2015 | 165 | 2015 |
Sport-related concussions: A review of epidemiology, challenges in diagnosis, and potential risk factors JM Noble, DC Hesdorffer Neuropsychology review 23 (4), 273-284, 2013 | 159 | 2013 |
‘Hip-Hop’Stroke A Stroke Educational Program for Elementary School Children Living in a High-Risk Community O Williams, JM Noble Stroke 39 (10), 2809-2816, 2008 | 131 | 2008 |
Merritt's neurology ED Louis, SA Mayer, LP Rowland Lippincott Williams & Wilkins, 2015 | 99* | 2015 |
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ... The Lancet Neurology 21 (4), 329-341, 2022 | 92 | 2022 |
Factors associated with the onset and persistence of post–lumbar puncture headache AE Monserrate, DC Ryman, S Ma, C Xiong, JM Noble, JM Ringman, ... JAMA neurology 72 (3), 325-332, 2015 | 91 | 2015 |
Child-Mediated Stroke Communication Findings From Hip Hop Stroke O Williams, A DeSorbo, J Noble, W Gerin Stroke 43 (1), 163-169, 2012 | 89 | 2012 |
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease SE Schindler, Y Li, KW Todd, EM Herries, RL Henson, JD Gray, G Wang, ... Alzheimer's & Dementia 15 (5), 655-665, 2019 | 88 | 2019 |
Dietary Patterns, Physical Activity, Sleep, and Risk for Dementia and Cognitive Decline C Zhao, JM Noble, K Marder, JS Hartman, Y Gu, N Scarmeas Current nutrition reports 7 (4), 335-345, 2018 | 82 | 2018 |
Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease BM Brown, HR Sohrabi, K Taddei, SL Gardener, SR Rainey-Smith, ... Alzheimer's & Dementia 13 (11), 1197-1206, 2017 | 65 | 2017 |